연구실적

• Accurately Controlled Tumor Temperature with Silica-Coated Gold Nanorods for Optimal Immune Checkpoint Blockade Therapy BIOMATERIALS RESEARCH, 2024, v.28, 24
  SCIE KCI dColl.
• Cancer cell-specific and pro-apoptotic SMAC peptide-doxorubicin conjugated prodrug encapsulated aposomes for synergistic cancer immunotherapy Journal of Nanobiotechnology, 2024, v.22 no.1, 109
  SCIE Scopus dColl.
• Implantable MicroLED-Mediated Chemo-Photodynamic Combination Therapy for Glioma Treatment Advanced Functional Materials, 2024, v.34 no.30, 2316386
  SCIE Scopus dColl.
• Mucoadhesive Mesalamine Prodrug Nanoassemblies to Target Intestinal Macrophages for the Treatment of Inflammatory Bowel Disease ACS Nano, 2024, v.18 no.25, 16297-16311
  SCIE Scopus dColl.
• Multi-functional nanomedicines for combinational cancer immunotherapy that transform cold tumors to hot tumors EXPERT OPINION ON DRUG DELIVERY, 2024, v.21 no.4, 627-638
  SCIE Scopus dColl.
• Nano-Delivery of Immunogenic Cell Death Inducers and Immune Checkpoint Blockade Agents: Single-Nanostructure Strategies for Enhancing Immunotherapy Pharmaceutics, 2024, v.16 no.6, 795
  SCIE Scopus dColl.
• Photo-induced crosslinked and anti-PD-L1 peptide incorporated liposomes to promote PD-L1 multivalent binding for effective immune checkpoint blockade therapy Acta Pharmaceutica Sinica B, 2024, v.14 no.3, 1428-1440
  SCIE Scopus dColl.
• Recent developments in chemodrug-loaded nanomedicines and their application in combination cancer immunotherapy Journal of Pharmaceutical Investigation, 2024, v.54 no.1, 13-36
  SCIE Scopus KCI dColl.
• Adoptive Transfer of Photosensitizer-Loaded Cytotoxic T Cells for Combinational Photodynamic Therapy and Cancer Immuno-Therapy Pharmaceutics, 2023, v.15 no.4, 1295
  SCIE Scopus dColl.
• All-in-one glycol chitosan nanoparticles for co-delivery of doxorubicin and anti-PD-L1 peptide in cancer immunotherapy Bioactive Materials, 2023, v.28, 358-375
  SCIE Scopus dColl.
• Cancer-Specific Delivery of Proteolysis-Targeting Chimeras (PROTACs) and Their Application to Cancer Immunotherapy PHARMACEUTICS, 2023, v.15 no.2, 411
  SCIE Scopus dColl.
• Enhanced delivery of the phototherapeutic nanoparticles via hepatocyte overload Colloids and Surfaces B: Biointerfaces, 2023, v.221, 112959
  SCIE Scopus dColl.
• Fluorescence-Based Mono- and Multimodal Imaging for In Vivo Tracking of Mesenchymal Stem Cells Biomolecules, 2023, v.13 no.12, 1787
  SCIE Scopus dColl.
• In situ albumin-binding and esterase-specifically cleaved BRD4-degrading PROTAC for targeted cancer therapy Biomaterials, 2023, v.295, 122038
  SCIE Scopus dColl.
• In vivo toxicity evaluation of tumor targeted glycol chitosan nanoparticles in healthy mice: repeated high-dose of glycol chitosan nanoparticles potentially induce cardiotoxicity JOURNAL OF NANOBIOTECHNOLOGY, 2023, v.21 no.1, 82
  SCIE Scopus dColl.
• Intracellular Glucose-Depriving Polymer Micelles for Antiglycolytic Cancer Treatment Advanced Materials, 2023, v.35 no.10, 2207342
  SCIE Scopus dColl.
• Micro-syringe chip-guided intratumoral administration of lipid nanoparticles for targeted anticancer therapy Biomaterials Research, 2023, v.27 no.1, 102
  Scopus dColl.
• Perspectives for Improving the Tumor Targeting of Nanomedicine via the EPR Effect in Clinical Tumors International Journal of Molecular Sciences, 2023, v.24 no.12, 10082
  SCIE Scopus dColl.
• Recent Studies and Progress in the Intratumoral Administration of Nano-Sized Drug Delivery Systems Nanomaterials, 2023, v.13 no.15, 2225
  SCIE Scopus dColl.
• Thermally Managed, Injectable Optoelectronic Probe with Heat Dissipation Guide for Photodynamic Therapy Small, 2023, v.19 no.35, 2300753
  SCIE Scopus dColl.
• Comparative study of cathepsin B-cleavable linkers for the optimal design of cathepsin B-specific doxorubicin prodrug nanoparticles for targeted cancer therapy Biomaterials, 2022, v.289, 121806
  SCIE Scopus dColl.
• Implantable micro-scale LED device guided photodynamic therapy to potentiate antitumor immunity with mild visible light Biomaterials Research, 2022, v.26 no.1, 56
  Scopus dColl.
• Injectable Hydrogel-Based Combination Cancer Immunotherapy for Overcoming Localized Therapeutic Efficacy Pharmaceutics, 2022, v.14 no.9, 1908
  SCIE Scopus dColl.
• Liposome-mediated PD-L1 multivalent binding promotes the lysosomal degradation of PD-L1 for T cell-mediated antitumor immunity Biomaterials, 2022, v.290, 121841
  SCIE Scopus dColl.
• Mesenchymal Stem Cell-Mediated Deep Tumor Delivery of Gold Nanorod for Photothermal Therapy Nanomaterials, 2022, v.12 no.19, 3410
  SCIE Scopus dColl.
• Molecularly engineered siRNA conjugates for tumor-targeted RNAi therapy Journal of Controlled Release, 2022, v.351, 713-726
  SCIE Scopus dColl.
• Preclinical development of carrier-free prodrug nanoparticles for enhanced antitumor therapeutic potential with less toxicity Journal of Nanobiotechnology, 2022, v.20 no.1, 436
  SCIE Scopus dColl.
• Prediction the clinical EPR effect of nanoparticles in patient-derived xenograft models Journal of Controlled Release, 2022, v.351, 37-49
  SCIE Scopus dColl.
• Tumor-Specific Monomethyl Auristatin E (MMAE) Prodrug Nanoparticles for Safe and Effective Chemotherapy PHARMACEUTICS, 2022, v.14 no.10, 2131
  SCIE Scopus dColl.
• [학술지논문] Thermally Managed, Injectable Optoelectronic Probe with Heat Dissipation Guide for Photodynamic Therapy SMALL, 2023, v.19 no.35 , 202300-202300
  SCIE
• [학술지논문] Comparative study of cathepsin B-cleavable linkers for the optimal design of cathepsin B-specific doxorubicin prodrug nanoparticles for targeted cancer therapy BIOMATERIALS, 2022, v.289 no.0 , 121806-121806
  SCI
• [학술지논문] Copper-Free Click Chemistry: Applications in Drug Delivery, Cell Tracking, and Tissue Engineering ADVANCED MATERIALS, 2022, v.34 no.10 , 2107192--
  SCI
• [학술지논문] Light-triggered photodynamic nanomedicines for overcoming localized therapeutic efficacy in cancer treatment ADVANCED DRUG DELIVERY REVIEWS, 2022, v.186 no.- , 114344--
  SCI
• [학술지논문] Liposome-mediated PD-L1 multivalent binding promotes the lysosomal degradation of PD-L1 for T cell-mediated antitumor immunity BIOMATERIALS, 2022, v.290 no.0 , 121841-121841
  SCI
• [학술지논문] Tumor-activated carrier-free prodrug nanoparticles for targeted cancer Immunotherapy: Preclinical evidence for safe and effective drug delivery ADVANCED DRUG DELIVERY REVIEWS, 2022, v.183 no.- , 114177--
  SCI
• [학술지논문] Cancer-activated doxorubicin prodrug nanoparticles induce preferential immune response with minimal doxorubicin-related toxicity BIOMATERIALS, 2021, v.272 no.- , 120791--
  SCI
• [학술지논문] Predicting in vivo therapeutic efficacy of bioorthogonally labeled endothelial progenitor cells in hind limb ischemia models via non-invasive fluorescence molecular tomography BIOMATERIALS, 2021, v.266 no.- , 120472--
  SCI
• [학술지논문] The safe and effective intraperitoneal chemotherapy with cathepsin B-specific doxorubicin prodrug nanoparticles in ovarian cancer with peritoneal carcinomatosis Biomaterials, 2021, v.279 no.- , 121189--
  SCI
• [학술지논문] Visible-Light-Triggered Prodrug Nanoparticles Combine Chemotherapy and Photodynamic Therapy to Potentiate Checkpoint Blockade Cancer Immunotherapy ACS NANO, 2021, v.15 no.7 , 12086-12098
  SCI